Stocks and InvestingStocks and Investing
Wed, March 17, 2021
Tue, March 16, 2021
Mon, March 15, 2021
Sun, March 14, 2021
Fri, March 12, 2021
Thu, March 11, 2021
Wed, March 10, 2021

Tazeen Ahmad Downgraded (ACAD) to Hold on, Mar 10th, 2021


Published on 2024-10-27 15:54:43 - WOPRAI, Tazeen Ahmad
  Print publication without navigation


Tazeen Ahmad of B of A Securities, Downgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Hold on, Mar 10th, 2021.

Tazeen has made no other calls on ACAD in the last 4 months.



There are 9 other peers that have a rating on ACAD. Out of the 9 peers that are also analyzing ACAD, 3 agree with Tazeen's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Neena Bitritto-Garg of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $35 on, Tuesday, March 9th, 2021
  • Paul Matteis of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $27 on, Tuesday, March 9th, 2021
  • Yatin Suneja of "Guggenheim" Downgraded from Strong Buy to Hold on, Tuesday, March 9th, 2021


These are the ratings of the 6 analyists that currently disagree with Tazeen


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $43 on, Tuesday, March 9th, 2021
  • Danielle Brill of "Raymond James" Downgraded from Strong Buy to Buy and Decreased Target to $35 on, Tuesday, March 9th, 2021
  • Jeffrey Hung of "Morgan Stanley" Maintained at Buy with Decreased Target to $50 on, Tuesday, March 9th, 2021
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $44 on, Tuesday, March 9th, 2021
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $40 on, Tuesday, March 9th, 2021
  • Vamil Divan of "Mizuho" Initiated at Strong Buy and Held Target at $69 on, Wednesday, December 16th, 2020